Alexion performance

If you would invest  9,169  in Alexion Pharmaceuticals Inc on April 21, 2013 and sell it today you would earn a total of  834  from holding Alexion Pharmaceuticals Inc or generate 9.1% return on investment over 30 days. Alexion Pharmaceuticals Inc is currenly generating 0.53% of daily expected returns and assumes 3.17% risk (volatility on return distribution) over the 30 days horizon. In different words, 41% of equities are less volatile than Alexion Pharmaceuticals Inc and 70% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.Given investment horizon of 30 days, Alexion Pharmaceuticals Inc is expected to generate 5.76 times more return on investment than the market. However, the company is 5.76 times more volatile than its market benchmark. It trades about 0.17 of its potential returns per unit of risk. The S&P 500 is currently generating roughly 0.56 per unit of risk.

Based on recorded statements Alexion Pharmaceuticals Inc has Operating Margin of 35.28%. This is 232.09% lower than that of Healthcare sector, and 136.7% lower than that of Biotechnology industry, The Operating Margin for all stocks is 1110.89% lower than the firm.

Alexion Pharmaceuticals Inc is rated below average in return on equity category among related companies. It is rated fifth in return on asset category among related companies reporting about  0.76  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Alexion Pharmaceuticals Inc is roughly  1.31 

Return On Equity ( % )

Return On Equity Return On Asset Profit Margin Operating Margin Current Valuation Shares Outstanding Shares Owned by Insiders Shares Owned by Institutions Number of Shares Shorted Price to Earning Price to Book Price to Sales Revenue Gross Profit EBITDA Net Income Cash and Equivalents Cash per Share Total Debt Debt to Equity Current Ratio Book Value Per Share Cash Flow from Operations Short Ratio One Year High One Year Low Earnings Per Share Price to Earnings To Growth Number of Employees Beta Market Capitalization Total Asset Retained Earnings Working Capital Current Asset Current Liabilities Z Score Probability Of Bankruptcy